The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
CHAI's Vaccines Program
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have, across the globe, averted two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974. The introduction of the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save a further ~1 million lives per year. Furthermore, great advances in the development and financing of new vaccines provides countries the opportunity to further reduce the burden of diseases such as human papillomavirus (HPV).
However, despite these successes, 1.5 million children still die each year of vaccine-preventable diseases. Many of these are in low-income countries, where immunization programs face unprecedented challenges in accessing vaccines and ensuring they reach all targeted children.
Since 2010, the Clinton Health Access Initiative (CHAI) has worked to save lives and reduce the burden from vaccine preventable diseases by improving access to immunization services in resource-limited setting. CHAI does this by strengthening national immunization programs at the country level, and the leveraging that experience to improve the global immunization ecosystem. Within that effort, CHAI is pursuing six complementary strategic goals:
CHAI's vaccine program closely supports the national immunization programs in 11 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Tanzania, Uganda and Vietnam - and also engages with global stakeholders such as Gavi, WHO and UNICEF to inform global policies and practices.
Improving Vaccines Supply Chains
Most vaccines must travel through supply chains containing between three and five—sometimes more—storage points to get to the last mile. In order to be available to be administered, vaccines must be correctly forecasted, ordered for accurately, managed well in-store, issued and selected for distribution accurately, and delivered on-time and in-full to their next destination. However, many countries struggle to keep all of these processes running smoothly, which threatens full stock availability at the last mile. Supply chains are further strained as countries introduce more vaccines to protect children from a wider range of diseases. For example, a recent study found that 38% of countries in Sub-Saharan Africa reported national-level stock-outs. When this happens, according to the study, there is an 89% chance that a stock-out will occur lower in the supply chain, often negatively affecting the last-mile.
To help ensure that children are able to access the full schedule of life-saving vaccines, CHAI supports supply chain work in several countries that is focused on ensuringthat certain core elements and practices are in place:
Base location is flexible, with strong preference for vaccine program focus countries. Significant travel (at least 35%) is expected.
Responsibilities for the Role
We are seeking an Associate to join the global vaccines delivery team to shape CHAI's work in vaccine supply chain globally and across all its focus countries, in collaboration with other global team associates and senior associates.
1) Provide high-value strategic and programmatic support to design and implement in-country initiatives which will dramatically improve vaccines supply chain performance, in collaboration with CHAI country teams.
2) Inform global practices and policies related to vaccines supply chain.
3) Support the development of CHAI's vaccines program around vaccines supply chain, in collaboration with program and country leadership
4) Support program and grant management, with a focus on vaccines supply chain work, in collaboration with program and country leadership